Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Tenax Therapeutics Inc TENX

Healthcare Biotechnology
Tenax Therapeutics, Inc., a clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201... see more

Current News (NDAQ:TENX)

Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment

GlobeNewswire December 17, 2025

Tenax Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire November 25, 2025

Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire November 12, 2025

Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF

GlobeNewswire November 6, 2025

Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

GlobeNewswire November 3, 2025

Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

GlobeNewswire September 16, 2025

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025

GlobeNewswire August 28, 2025

Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire August 13, 2025

Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire May 14, 2025
View More News ››

Opinion & Analysis (NDAQ:TENX)

Did investors in Trilogy Energy (T.T.TET) overreact to disappointing news?

Stockhouse Editorial November 8, 2013
View More Opinion ››

Bullboard Posts (NDAQ:TENX)

TENX ...... Early a.m runner on NR....big $ financing !!!!

Cha F'king Ching !!!!!!!!
Iseneschal - August 6, 2024

Tenax Therapeutics, Inc. (NASDAQ:TENX): Advancing Levosimend

http://beyondspx.com/2024/08/01/tenax-therapeutics-inc-nasdaqtenx-advancing-levosimendan-for-pulmonary-hypertension-with-promising...
MikeTester - August 1, 2024

TENX .....on watch for slight vol increase & $ appreciation

Over $3 now
Iseneschal - July 2, 2024

TENX.....Nothing lasts forever....Shave & a Haircut P.O

  Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering   2024-02-08 05:17 ET - News Release...
Iseneschal - February 8, 2024

TENX .....Yeeehaaaa ...What a start this a.m

Almost a 300% win Cha F'king Ching !!!!
Iseneschal - February 6, 2024

RE:TENX ....I've had this on my "to buy" list

And to add: This is RS #5 All this Co. wants is your money.....you better be selective when u buy this pos
Iseneschal - January 29, 2024
View more Bullboard ››

Blue Sky Uranium Corp.

Blue Sky Uranium Corp.

Blue Sky Uranium Corp., a junior uranium exploration company, engages in the acquisition, exploration, and evaluation of ...
View More »

Podcasts